Ketamine’s double-edged sword: Therapeutic benefits and adverse events in adolescent treatment-resistant OCD - A case series
Background: About one-third of obsessive-compulsive disorder (OCD) cases show poor response to first-line treatments. Ketamine’s role in modulating glutamate, implicated in OCD pathogenesis, warrants investigation. Cases: Four adolescents with treatment-resistant OCD received ketamine infusion (0.5...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-06-01
|
| Series: | Indian Journal of Psychiatry |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/indianjpsychiatry_1144_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Background:
About one-third of obsessive-compulsive disorder (OCD) cases show poor response to first-line treatments. Ketamine’s role in modulating glutamate, implicated in OCD pathogenesis, warrants investigation.
Cases:
Four adolescents with treatment-resistant OCD received ketamine infusion (0.5 mg/kg) every other day for six sessions with monitoring using the Children’s Yale-Brown Obsessive Compulsive Scale (C-YBCOS) and Clinician-Administered Dissociative State Scale (CADSS). Three patients showed progressive improvement after multiple infusions with maintained benefits at 2-month follow-up. One patient developed ketamine-induced psychosis.
Conclusion:
Ketamine shows promise as adjuvant treatment in adolescent OCD, though psychomimetic risks require careful consideration. |
|---|---|
| ISSN: | 0019-5545 1998-3794 |